Regeneron Reports First Quarter 2023 Financial and Operating Results
First quarter 2023 revenues increased 7% to $3.16 billion versus first quarter 2022First quarter 2023 Dupixent® global net sales increased 37% to $2.49 billion versus first quarter 2022First... | May 4, 2023